⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8164385 | 1.00 | — | — | |
| SCHEMBL337118 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL16095751 | 0.98 | SSTR4 (0.47) | — | |
| SCHEMBL27595403 | 0.98 | SSTR4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL16094440 | 0.98 | SSTR4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL1609138 | 0.98 | SSTR4 (0.47) | — | |
| Trifluoroacetic Acid SCHEMBL19551067 | 0.89 | SSTR4 (0.46) | — | |
| SCHEMBL24502684 | 0.87 | SLC6A1 (0.45) | — | |
| SCHEMBL30194780 | 0.87 | SLC6A1 (0.45) | — | |
| SCHEMBL30987164 | 0.85 | SLC6A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024506-B2 | Compounds | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-07-02 | — | — | US | claimed |
| EP-3743421-B1 | COMPOUNDS | UNIV OXFORD INNOVATION LTD (GB) | 2023-03-29 | — | — | EP | claimed |
| US-20210009576-A1 | COMPOUNDS | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2021-01-14 | — | — | US | claimed |
| EP-3743421-A1 | COMPOUNDS | Oxford University Innovation Limited (GB) | 2020-12-02 | — | — | EP | claimed |
| WO-2019145718-A1 | COMPOUNDS | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2019-08-01 | — | — | WO | claimed |
| EP-2616070-B1 | NOVEL TRIAZOLE DERIVATIVES WITH IMPROVED RECEPTOR ACTIVITY AND BIOAVAILABILITY PROPERTIES AS GHRELIN ANTAGONISTS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS | AETERNA ZENTARIS GMBH (DE) | 2018-02-14 | — | — | EP | claimed |
| US-8546435-B2 | Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors | AETERNA ZENTARIS GMBH (DE) | 2013-10-01 | — | — | US | claimed |
| EP-2616070-A1 | NOVEL TRIAZOLE DERIVATIVES WITH IMPROVED RECEPTOR ACTIVITY AND BIOAVAILABILITY PROPERTIES AS GHRELIN ANTAGONISTS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS | Æterna Zentaris GmbH (DE) | 2013-07-24 | — | — | EP | claimed |
| WO-2012035124-A1 | NOVEL TRIAZOLE DERIVATIVES WITH IMPROVED RECEPTOR ACTIVITY AND BIOAVAILABILITY PROPERTIES AS GHRELIN ANTAGONISTS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS | ÆTERNA ZENTARIS GMBH (DE) | 2012-03-22 | — | — | WO | claimed |
| US-20250345341-A1 | 4-Pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament | BOEHRINGER INGELHEIM INT (DE) | 2025-11-13 | — | — | US | disclosed |
| EP-4572759-A2 | THIAZOLE DERIVATIVES FOR THERAPEUTIC USE | Nimml Institute (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20240376099-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | NOVARTIS AG (CH) | 2024-11-14 | — | — | US | disclosed |
| US-20240246978-A1 | PHENYLDIHYDROPYRIMIDINE COMPOUND AND USE THEREOF | Hepagene Therapeutics (HK) Limited (CN) | 2024-07-25 | — | — | US | disclosed |
| US-12024506-B2 | Compounds | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2024-07-02 | — | — | US | disclosed |
| US-5955433-A | DERIVATIVES OF B-CYCLOHEXYLALANINE-PROLINE-AGMATINE ARE ADMINISTERED AS ANTICOAGULANTS | ASTRA AKTIEBOLAG (SE) | 1999-09-21 | — | — | US | disclosed |
| US-5747460-A | Method of treatment and prophylaxis of venous thrombosis | ASTRA AKTIEBOLAG (SE) | 1998-05-05 | — | — | US | disclosed |
| US-5736521-A | ADMINISTERING AMINO ACID COMPOUND | ASTRA AKTIEBOLAG (SE) | 1998-04-07 | — | — | US | disclosed |
| US-5614499-A | ANTICOAGULANTS; TREATMENT OR PROPHYLAXIS OF THROMBOSIS | ASTRA AKTIEBOLAG (SE) | 1997-03-25 | — | — | US | disclosed |
| EP-0618926-A1 | NEW PEPTIDE DERIVATIVES | Astra Aktiebolag (SE) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993011152-A1 | NEW PEPTIDE DERIVATIVES | AKTIEBOLAGET ASTRA (SE) | 1993-06-10 | — | — | WO | disclosed |